글로벌 약물 발견 아웃소싱 시장 – 2028년까지의 산업 동향 및 예측

약물 발견 아웃소싱의 시장 분석 및 통찰력

약물 발견 아웃소싱 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 2028년까지 시장이 56억 5천만 달러에 이를 것으로 분석하고, 위에 언급된 예측 기간 동안 8.75%의 CAGR로 성장할 것이라고 예측했습니다.

약물 발견 아웃소싱은 약리학, 제약 및 생명공학과 같은 다양한 분야에서 새로운 의약품이나 약물을 찾는 데 사용되는 절차입니다. 또한 약물 발견 아웃소싱은 약물 개발 프로세스의 시작 단계입니다.

전 세계적으로 약물 발견 연구 파트너십의 증가 추세는 약물 발견 아웃소싱 시장의 성장과 수요를 강화하는 중요한 요인 중 하나입니다. 또한 대사, 유전 및 기타 만성 질환의 유병률 증가와 약물 발견의 기술 발전도 2021년에서 2028년까지의 예측 기간 동안 글로벌 시장 성장에 기여하고 있습니다. 또한 약물 발견에서 AI 사용 증가와 특허 만료, 생물학으로의 빠른 전환, 대형 제약 회사의 내부 발견의 전례 없는 축소도 시장 성장을 강화하고 있습니다. 항생제 내성과 약물 내성의 증가도 예측 기간 동안 높은 산업 성장을 보장할 것입니다.

선도적인 제약 및 생명공학 기업 의 강력한 입지 와 제약 회사가 약물 개발 효능을 개선하고 새로운 약물을 신속하게 개발하는 데 더욱 집중함에 따라 2021년에서 2028년까지의 예측 기간 동안 시장에 상당한 성장 기회가 제공될 것입니다.

그러나 높은 비용과 약물 실패의 높은 위험은 약물 발견 아웃소싱 시장의 성장을 억제할 것이고, 숙련된 전문가의 부족은 약물 발견 아웃소싱 시장의 성장에 도전이 될 가능성이 있습니다.

This drug discovery outsourcing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on drug discovery outsourcing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Drug Discovery Outsourcing Market Scope and Market Size

Drug discovery outsourcing market is segmented on the basis of drug type, workflow and therapeutic area. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on drug type, the drug discovery outsourcing market is segmented into small molecules and large molecules.
• On the basis of workflow, the drug discovery outsourcing market is segmented into target identification and screening, target validation and functional informatics, lead identification and candidate optimization, preclinical development and others.
• The therapeutic area segment of drug discovery outsourcing market is segmented into respiratory system, pain and anaesthesia, oncology, ophthalmology, haematology, cardiovascular, endocrine, gastrointestinal, immunomodulation, anti-infective,  central nervous system, dermatology and genitourinary system.

 Drug Discovery Outsourcing Market Country Level Analysis

Drug discovery outsourcing market is analyzed and market size insights and trends are provided by country, drug type, workflow and therapeutic area as referenced above.

The countries covered in the drug discovery outsourcing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the drug discovery outsourcing market owing to the high adoption of technological advancements as well as the strong presence of well-established research infrastructure and increasing investments in drug discovery R&D within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the increasing trend of outsourcing manufacturing and R&D activities to countries such as China and India within this particular region.

The country section of the drug discovery outsourcing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Drug discovery outsourcing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for drug discovery outsourcing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug discovery outsourcing market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Drug Discovery Outsourcing Market Share Analysis

Drug discovery outsourcing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to drug discovery outsourcing market.

약물 발견 아웃소싱 시장 보고서에서 다루는 주요 업체는 Charles River Laboratories, Albany Molecular Research Inc., Thermo Fisher Scientific, Jubilant Biosys, Eurofins Scientific, GVK Biosciences Private Limited, Aurigene Pharmaceutical Services Ltd., Selvita, Dalton Pharma Services, QIAGEN, Syngene International Limited, SRI INTERNATIONAL, Merck KGaA, Covance Inc., Nanosyn, Bioduro, Sygnature Discovery, Laboratory Corporation of America Holdings, Domainnex, GenScript 등 국내 및 글로벌 업체입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-34602